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ABSTRACT
Objective: To describe pattern of female genital tract cancers seen at Olabisi Onabanjo 
University Teaching Hospital (OOUTH), Sagamu, Nigeria.
Design: This is a retrospective review of all cases of female genital tract cancers managed 
at the Gynaecology department of OOUTH, Sagamu, Nigeria.
Setting: OOUTH is a tertiary health institution of the State’s university and it takes 
referrals from within and outside the State.
Subjects: Case records of all female genital tract cancers managed between January 
2004 and December 2013 were retrieved and analysed using SPSS version 16.0.
Results: There were 2059 women treated for various gynaecologic conditions, 179 (8.7%) 
were cases of female genital tract cancers and 161 records were available for analysis. 
Cervical cancer constituted the commonest (51.6%), followed by ovarian (35.4%), 
endometrial (9.9%), and choriocarcinoma (1.9%). There were no cases of vaginal and 
fallopian tube cancers. The lowest mean age was found in choriocarcinoma (36.60 ±4.50 
years) and highest in vulvar cancer (70.00 ±2.82 years). The mean ages for cervical, 
endometrial and ovarian cancers were (51.98±12.39), (65.38±7.24), and (54.42±10.51) years 
respectively. Similarly the least mean parity was found in choriocarcinoma (2.33±1.52), 
and the highest in vulvar cancer (6.00±1.44). The mean parity for cervical, endometrial, 
and ovarian were (4.10±1.49), (3.06±1.48), and (3.72±1.68) respectively. These differences 
are statistically significant, age; F= 7.61, p<0.0001, and parity; F= 3.27, p= 0.013.
Conclusion: Incidence of cervical, endometrial, and ovarian cancers remain high and 
presentations are at late stages. There is a need to improve on cervical cancer screening, 
and for the attending physicians to improve on their indices of suspicions as regards 
endometrial and ovarian cancers.
INTRODUCTION
In 2012 it was estimated that there would be annual 
incidence of 14.1 million new cancer cases in both men 
and women worldwide and that women would share 
47.3% of this burden(1). Similarly annual incidence of 
cancer cases in women was estimated to be over 6.6 
million and female genital tract cancers constituted 
1.1 million (16.7%) of the burden(1,2). Cancers of the 
female genital tract, namely cervix, endometrium 
or corpus uteri, ovary, vulva, fallopian tubes, and 
gestational trophoblastic cancers (choriocarcinoma 
and placental site trophoblastic tumours) are 
important causes of cancer morbidity and mortality 
in women worldwide(3). While cancers of the vulva, 
vagina, fallopian tubes and choriocarcinoma are very 
rare, cancers of the cervix, endometrium and ovary 
account largely for cancer morbidity and mortality 
in women (4,5).
 Globally, and in Nigeria, the incidence of female 
genital tract cancers have been on the increase since 
the past decade and a half, cervical cancer that is 
the 3rd most common cancer in women remains the 
commonest genital tract malignancy, and current 
global estimations are 527624 new cases and 265653 
deaths annually (1,2,5,6,7). This global increase in 
incidence of female genital tract cancers are probably 
as a result of increased awareness rather than actual 
increase in number, particularly now in the less 
developed countries. (3)
 In our practice, as in other less developed 
countries, women with genital tract cancers report 
very late for medical care due to ignorance and 
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poverty (4,7). In addition screening services are still 
non-existent, or at best few and opportunistic (8,9).
 The aim of this study was to describe the pattern 
and frequency of different types of female genital 
cancers, age, parity, histological diagnoses, treatment 
and outcome of management that were managed at 
the gynaecological department of Olabisi Onabanjo 
University Teaching Hospital, Sagamu, Nigeria.
MATERIALS AND METHODS
Case records of all cases of histologically confirmed 
cancers of the female genital organs managed in the 
gynecological department between 1st January, 2004 
and 31st December 2013 were retrieved from Medical 
records department and data on socio-demographic 
status, age, parity, mode of presentation, clinical 
and histological diagnoses, mode of treatment 
and outcome were collated using a proforma and 
analysed. Additional information, when necessary, 
was obtained from the gynecological ward, operating 
room and morbid anatomy records. 
 Data were analysed using statistical package 
for the social sciences (SPSS) version 16.0. Statistical 
analysis was performed using chi-square test for 
categorical variables and the two-tailed t-test for 
continuous variables. One-sample t-test was used 
in comparing means with known means from 
population records or data. One-way analysis of 
variance was used to evaluate the difference in the 
means of multiple variables. The results are presented 
as means, standard deviation, and range; or as 
frequency and percentages, and p-value <0.05 was 
considered significant.
 Olabisi Onabanjo University Teaching Hospital, 
Sagamu, is a tertiary health institution that takes 
referrals from other neighbouring government and 
private health institutions in Ogun State. The hospital 
also takes referrals from health institutions in the 
neighbouring towns of Lagos, Oyo and Ondo States 
that share borders with it.
RESLUTS
Between January 2004 and December 2013, 2059 
women were admitted and managed for various 
gynaecological disorders, 179 (8.7%) were cases of 
various gynaecologic cancers. One hundred and sixty-
one case notes were retrieved for analysis. The ages 
of the women ranged between 32 and 82 years and 
the mean was 54.11 (±12.10) years. The parity ranged 
from 0 and 8 and the mean parity was 3.85 (±1.60).
Table 1
Socio-demographic characteristics of women treated for genital tract cancers at Olabisi Onabanjo University 
Teaching Hospital, Sagamu between January 2004 and December 2013
Variable Frequency Percentage (%)
Age (n=161)
≤10 0 0.0
11 - 20 0 0.0
21 – 30 0 0.0
31 – 40 26 16.1
41 – 50 42 26.1
51 – 60 51 31.7
61 – 70 17 10.6
71 – 80 21 13.0
81 – 90 4 2.5
≥91 0 0.0
Parity (n=161)
0 - 2 42 26.1
3 - 5 99 61.5
≥ 6 22 12.4
Marital status (161)
Single/Never married 3 1.9
Married/Living together 112 69.6
Separated/Divorced 2 1.2
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Widow 25 15.5
Not stated 19 11.8
Educational status (161)
Nil education 36 22.4
Primary school 34 21.1
Secondary school 59 36.6
Post-secondary school 20 12.4
Tertiary education 9 5.6




Traditional Religion 9 5.6





Southern minority 2 1.2
Northern minority 3 1.9
Not stated 9 5.6
Table 2
Frequency distribution of types of female genital tract cancer their and mean age and parity at presentation at the 
Olabisi Onabanjo University Teaching Hospital, Sagamu between January 2004 and December 2013
Variable Type of cancer Frequency Percentage (%) Mean (±SD) Range
Age (in years)
Vulvar cancer 2 1.2 70.00(±2.82) 68 - 72
Vaginal cancer 0 0.0 0.0 0.0
Cervical cancer 83 51.6 51.98(±2.39) 36 - 82
Endometrial 
cancer
16 9.9 65.38(±7.24) 53 - 76
Ovarian cancer 57 35.4 54.42(±10.51) 34 - 75
Fallopian tube 
cancer
0 0.0 0.0 0.0
Choriocarcinoma 3 1.9 36.6(±4.50) 32 - 41
161 100.0 54.11(±12.10) 32 - 82
Parity
Vulvar cancer 2 1.2 6.00(±1,41) 5 – 7
Vaginal cancer 0 0.0 0.0 0
Cervical cancer 83 51.6 4.10(±1.49) 1 – 8
Endometrial 
cancer
16 9.9 3.06(±1.48) 1 - 5
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Table 1 demonstrates the socio-demographic 
characteristics of women treated for genital tract 
cancers at the OOUTH Sagamu. Twenty-six (16.1%) 
of the women were aged 40 years and below, 134 
(68.4%) were aged between 40 and 70 years, and 25 
(15.5%) were above 70 years.
 Forty-two (26.1%) women had 2 or less parous 
experience, 99 (61.5%) had 3 to 5 parous experience, 
and 20 (12.4%) were grandmultiparae.
 Majority of the women, 112 (69.6%), were either 
married or living with their spouses. Three (1.9%) 
were either never married or single, 25 (15.5%) 
were widows, and 2 (1.2%) were either separated or 
divorced. Marital status were not noted in 19 (11.8%) 
of the women.
 Eighty-eight (54.6%) of the women had at least 
secondary school and 36 (22.4%) had no formal 
education.
 Other socio-demographic characteristics of 
religion and tribes are as noted in the table.
 Table 2 shows frequency of occurrences of female 
genital tract cancers and their mean age and parity 
at presentation at OOUTH Sagamu, Nigeria between 
January 2004 and December 2013. Cervical cancer 
was the commonest female genital cancers 83 (51.6%), 
followed by ovarian 57 (35.4%) and then endometrial 
/uterine corpus 16 (9.9%). There were 2 (1.2%) cases 
of vulvar cancer and 3(1.9%) choriocarcinoma. There 
was no case of vaginal and fallopian tube cancers.
Figure 1
Pie chart showing percentage distribution of female genital tract cancers managed at the Olabisi Onabanjo 
University Teaching Hospital, Sagamu between January 2004 and December 2013







Figure 1 was a pie chart showing percentage 
distribution of cases of female genital tract cancers 
managed at the OOUTH Sagamu.
 Table 3 demonstrates comparison of means of 
ages and parity between cervical cancer and other 
types of female genital tract cancers that was managed 
at the teaching hospital. The observed differences in 
the means of both age (F = 7.61; p<0.0001) and parity 
(F = 3.27; p =0.013) amongst the women were 
statistically significant.
 Table 4 demonstrates histopathological 
characteristics of female genital tract cancers that 
Ovarian cancer 57 35.4 3.72(±1.68) 0 – 7
Fallopian tube 
cancer
0 0.0 0.0 0
Choriocarcinoma 3 1.9 2.33(±1.52) 1 - 4
161 100.0 3.85(±1.60) 0 - 8
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were managed in OOUTH during the study period. 
Vulvar and cervical cancers were mainly squamous 
cell types, and cancers of the endometrium and 
ovary shared different differentiations and grades 
of adenocarcinoma varieties. The choriocarcinomas 
were mainly of the gestational type.
 Table 5 demonstrates different stages of 
advancement of the diseases at presentation. Fifteen 
(9.3%) cases only presented at the early stages of the 
disease, and 146(90.7%) presented at late stages of the 
disease.
 Table 6 shows the different treatment modalities 
for the tumours.  Seventy-four (46%) of the cases, 
largely advanced stages of cervical cancer, could 
only have preliminary assessment that included 
examination under anaesthesia and taking of 
biopsy for histological diagnosis before referral to 
more resourceful centers for further management. 
Seven (4.3%) patients had radical hysterectomies 
(Weirthem’s hysterectomies) for early stage 
cervical cancer diseases. Irrespective of the stage 
at presentation majority of the ovarian cancer 
cases had surgery (total abdominal hysterectomy, 
bilateral salpingoophorectomy (TAH and BSO), 
infracolic omentectomy and removal of suspicious 
nodes and tumour deposits on the guts, abdomen 
and the diaphragm, and were then followed up 
by chemotherapy. Similarly early stage disease of 
endometrial cancer had TAH and BSO. Fourteen 
(8.4%) cases were terminally ill and could only have 
palliation treatment offered.
Table 3
Comparison of mean age and parity between cervical cancer and other female genital tract cancers managed at the 









Lower Bound Upper Bound
Age
Cervical ca. Vulvar ca. -18.02 0.044 -18.024 8.818
Endomet ca. -13.39 0.000 -18.000 8.798
Ovarian ca. -2.44 0.225 -6.413 1.523
Choriocarc 15.30 0.037 15.309 7.208
                                    
Parity
Cervical ca. Vulvar ca. -1.90 0.079 -4.030 0.223
Endomet ca. 1.03 0.013 0.225 1.843
Ovarian ca. 0.37 0.166 -0.159 0.913
Choriocarc 1.76 0.048 0.015 3.511
Table 4
Histopathologic characteristics of Female Genital tract cancers treated at the Olabisi Onabanjo University Teaching 
Hospital, Sagamu, Nigeria between January 2004 and December 2013
Type of cancer Frequency Percentage (%)
Vulvar cancer
Squamous cell carcinoma 2 1.2
Vaginal cancer - -
Cervical cancer
1. Squamous cell carcinoma 78 48.4
2. Adenocarcinoma 2 1.2
3. Adenosquamous carcinoma 3 1.9
Endometrial cancer
95% Confidence Interval
( F = 7.61;    p <0.0001 )
( F = 3.27;     p = 0.013 )
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1. Endometriod adenocarcinoma 11 6.8
2. Serous adenocarcinoma 4 2.5
3. Leiomyosarcoma 1 0.6
Ovarian cancer
1. Papillary serous adenocarcinoma 34 21.1
2. Mucinous adenocarcinoma 9 5.6
3. Endometriod adenocarcinoma 4 2.5
4. Clear cell carcinoma 1 0.6
5. Dysgerminoma 3 1.9
6. Granulosa cell carcinoma 4 2.5




1. Choriocarcinoma 3 1.9
161 100.0
Table 5
Female Genital tract cancers and their clinical and surgical stages at presentation and management at the Olabisi 
Onabanjo University Teaching Hospital, Sagamu, Nigeria.
1A 1B 1c 2A LRC 2B 2C 3A 3B 3C 4A 4B HRC
Vulvar cancer _ _ _ _ 1 _ 1 _ _ _ _ _
Vaginal cancer _ _ _ _ _ _ _ _ _ _ _ _
Cervical cancer _ _ _ 7 _ 21 _ 14 33 _ 8 _ _
Endometrial 
cancer
_ _ 4 1 _ 9 _ _ 2 _ _ _ _
Ovarian cancer _ 3 _ _ 15 8 20 2 7 2 _ _
Faloopian tube 
cancer
_ _ _ _ _ _ _ _ _ _ _ _
Choriocarcinoma _ _ _ _ _ _ _ _ _ _ _ 3
_ 3 4 8 _ 46 8 35 37 7 10 _ 3
  
Table 6
Treatment modalities for Female Genital tract cancers that presented at the Olabisi Onabanjo University Teaching 
Hospital, Sagamu, Nigeria between January 2004 and December 2013
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Cervical 
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Endo-metrial 
cancer
_ _ _ 9 _ 7 _
Ovarian 
cancer
2 _ 9 _ _ 46 _
Fallopian 
tube cancer
_ _ _ _ _ _ _
Chorio-
carcinoma
_ _ _ _ _ _ 3
14 1 9 74 7 53 3
Table 7
Outcome of management in women who presented with female genital tract cancers at the Olabisi Onabanjo 
University Teaching Hospital, Sagamu, Nigeria between January 2004 and December 2013
Cancer Type Alive & Referred Alive & Discaharged Declined Medical Advice Dead
Vulval cancer - - 2 -
Vaginal cancer - - - -
Cervical cancer 63 8 8 4
Endometrial cancer   5 - 7 4
Ovarian cancer 12 22 4 19
Fallopian tube cancer - - - -
Choriocarcinoma - - 2 1
80 30 23 28
Table 7 demonstrates outcome of the management 
at the teaching hospital. About half of these cancers, 
80(49.7%) had to be referred outside the hospital for 
lack of either manpower or infrastructures to offer 
optimal management. The two cases of the vulvar 
cancer declined further management following 
surgery in one and an initial evaluation in the other. 
Majority of the cervical cancer cases were referred 
for radiotherapy, 8 declined management after initial 
evaluation and 4 died during evaluation. Highest 
morbidity was found in ovarian cancer and many 
others that were referred or discharged were lost to 
follow-up. Two out the 3 cases of choriocarcinoma 
declined or could not complete treatment and one 
died while on evaluation and treatment.
DISCUSSION
During this study period gynaecologic cancers formed 
8.7% of the total gynaecological ward admission, a 
figure considered high when compared with findings 
of 2.8% from Ghana by Nkyekyer, and 4.18% by 
Briggs in Port Harcourt, and 4.7% Emembolu in Zaria 
Nigeria (10-12). It however compares with findings 
of 10.7% by Yakassai and others in Kano, northern 
Nigeria in 2013 (7). The comparable incidence with 
later studies as against earlier studies would most 
likely be related to period of study. Yakassai and 
others’ study was recent and that of Nkyekyer, Briggs 
and Emembolu were findings over a decade when 
knowledge and awareness in cancer disease and 
management among the populace was not as high 
as it is currently. Hitherto cancerous diseases were 
considered afflictions from the devils, or witches, and 
only very few of the patients presented in the hospital 
for treatments while the majority sought traditional 
remedies. In other Low and middle income countries 
where awareness and knowledge among the citizenry 
is better and facilities are more resourceful incidence 
can be as high as 42.52% (13).
 Cervical cancer remains the leading cause of 
cancer morbidity and death in women worldwide, 
second only to breast in women, and the commonest 
female genital tract cancers (1,2). Similarly, findings in 
this study demonstrated cervical as the most common 
female genital tract cancer, occurring in 51.6% of the 
cases. This finding is similar to findings of 59.2% by 
Galadanci and 48.6% by Yakassai in Kano northern 
Nigeria, and 58.6% by Nkyekyer in Ghana (6,7,10). 
It is, however, lower than a rate of 63% found in 
the same institution at a 3-year review of 65 histo-
pathological specimens of cases of female genital 
cancers seven years ago (14). Values higher than these 
had been found in Nigeria and other sub-Saharan 
countries; 70.5% in Maiduguri, 73.1% in Ilorin and 
73.6% in Port Harcourt, all in Nigeria, and 78% in 
Zimbabwe (15-18). In advanced countries of Europe 
and America the incidence of and mortality from 
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cervical cancer are not only low but lower than that 
of the endometrium (1,2,3,5,19,20). This is consequent 
upon effective cervical cancer screening programmes 
in these countries, thus preventing progression from 
premalignant lesions to invasive diseases. 
 Age and parity are important epidemiological 
risk factors in gynaecologic cancers. While cancers 
of the vulva and vagina are diseases of the elderly, 
from above the seventh decade of life, that of the 
cervix and ovary tend to occur at relatively younger 
age, occurring in the fifth and sixth decades (4,21). 
Like other studies before this there were findings of 
statistically significant difference between the mean 
ages of patients with different gynaecological cancers 
(6). In this study similar observation was established 
in this study; F= 7.61, p < 0.0001. Similar finding was 
demonstrated in the parity; F=3.21, p = 0.013 (Table 
3). 
 Vulvar cancer occurred at ages over 65 years 
in this study, while there was no case of vaginal 
and fallopian tube cancers, (Table 2). The mean 
age of occurrence for cervical and ovarian cancers 
are comparable (51.98 vs 54.42, MD -2.44, 95%CI 
-6.41 – 1.52, p=0.225). Similar findings were made in 
concerning parity for cervical and ovarian cancers 
(4.10 vs 3.72, MD 0.37, 95%CI -0.15 – 0.91, p = 0.166). 
However differences in age and parity between 
cervical or ovarian cancers and endometrial cancer 
are statistically significant, though stronger for age 
than parity. Finding for age between cervical and 
endometrial cancers are; 51.98 vs 65.38, MD -13.39, 
95%CI -18.000 – 8.798, p < 0.0001. And for parity; 
4.10 vs 3.06, MD 1.03, 95%CI 0.225 – 1.843, p = 0.013). 
The implications from these findings are that older 
and less parous women are more likely to develop 
endometrial cancer than as for cervical and ovarian 
cancers.
 Following cancer of the cervix in order of 
occurrences are ovarian cancer 35.4%, endometrial 
cancer 9.9%, choriocarcinoma 1.9%, and vulva 1.2%. 
These findings are similar to other studies in similar 
environment (5-7,10-12,14-18). 
 Histo-pathological characteristics (table 4) are 
similar to findings in other studies in our environment 
and developing countries (. Squamous cell carcinoma 
are the predominant invasive cervical and vulvar 
cancers. Other histological types of invasive cervical 
cancer are adenocarcinoma and adenosquamous 
carcinoma (10-12,14-18). Different histologic 
types of adenocarcinoma were most expressed in 
endometrial and ovarian cancers. While endometroid 
adenocarcinoma was mostly found in endometrial 
cancer, serous adenocarcinoma was the most common 
in ovarian cancer, occurring in 34(21.1%) of the cases. 
Other common histological types in ovarian cancer 
were mucinous adenocarcinoma (5.6%), granulosa cell 
(2.5%) carcinoma and endometroid adenocarcinoma 
(2.5%). Clear cell carcinoma was the least commonly 
encountered, found in one case throughout the 
ten-year study period. These findings are similar to 
findings by Yakassai in Kano, Agboola and others in 
Sagamu and Odukogbe in Ibadan (7, 14, 22).
 Table 5 demonstrates stages of advancement 
of the diseases at presentation. Majority of the cases 
146(90.7%) presented at the late stages of the disease 
and only few 15(9.3%) presented at stages that could 
be described as early stage disease for meaningful 
and beneficial interventions. This scenario is peculiar 
to studies from other parts of the country and other 
developing countries (6,7,10,13,15,18). About a third 
of endometrial cancers presented very early and more 
than half presented at the lower extreme of the late 
stage. This finding is peculiar with endometrial cancer 
and has to do with symptomatology of endometrial 
cancer that is usually dramatic and alarming (23). 
Cervical and ovarian cancers are known for presenting 
in late stages in developing countries due to lack of 
screening programmes and infrastructures, and low 
index of suspicions on the part of attending physicians 
(1,2). In this study over 90% of both cancers of the 
cervix and ovary presented at the advance stages 
of the diseases culminating in very little that could 
be done in treatment and outcome of management 
(Tables 6 and 7). Examination under anaesthesia 
for clinical staging and taking biopsy specimens 
for histological diagnosis was all that could be 
done for 64(77.1%) and 9(56.2%) of the cervical and 
endometrial cancer cases respectively. Twelve (14.5%) 
of cervical cancer cases were so terminally ill that 
only palliative supports could be offered as treatment 
options. Forty-six (86.8%) cases of ovarian cancers 
had total abdominal hysterectomy, bilateral salpingo-
oophorectomy and infra-colic omentectomy and then 
planned for chemotherapy. Only few showed up for 
chemotherapy and majority of these abandoned or 
declined treatment. Finding of commonest fatality in 
ovarian cancer cases over other types of cancers in 
this study may not be representative of case fatality 
for comparison as majority of other cancers, especially 
cervical cancer, had to be referred outside the facility 
for further evaluation and treatment, and majority of 
the few that were managed were lost to follow up.
CONCLUSION
This study had demonstrated the burden of female 
genital tract cancers in our practice, and high incidence 
of cervical and ovarian cancers in our community. 
The study agrees with rarity of vulvar, vaginal and 
fallopian tube cancers as noted worldwide. Incidence 
of 51.6% of cervical cancer is high and this implies 
that a lot more efforts would be required at screening 
for premalignant diseases to prevent progression to 
invasive disease. Similarly the incidence of 35.4% of 
ovarian cancer is equally high. While there might be 
no guideline, currently, for screening in ovarian cancer 
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there is a need for physicians in our environment 
to develop high index of suspicions for women 
that present with suspicious symptomatology at 
consultations.
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